Paper33737232
Atrial resting membrane potential confers sodium current sensitivity to propafenone, flecainide and dronedarone.
Holmes AP and 15 others. Heart Rhythm, 2021. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Atrial resting membrane potential confers sodium current sensitivity to propafenone, flecainide and dronedarone. Papers, record 33737232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33737232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Atrial resting membrane potential confers sodium current sensitivity to propafenone, flecainide and dronedarone.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Atrial Fibrillation | Major topic |
| Dronedarone | Major topic |
| Flecainide | Major topic |
| Heart Atria | Major topic |
| Membrane Potentials | Major topic |
| Propafenone | Major topic |
| Sodium | Major topic |
| Action Potentials | |
| Animals | |
| Anti-Arrhythmia Agents | |
| Disease Models, Animal | |
| Female | |
| Male | |
| Mice | |
| Voltage-Gated Sodium Channel Blockers |
Source PubMed
Grants11
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Wellcome Trust | United Kingdom | PubMed | ||
| 109604/Z/15/Z | Wellcome Trust | United Kingdom | PubMed | |
| PG/17/30/32961 | British Heart Foundation | United Kingdom | PubMed | |
| FS/13/43/30324 | British Heart Foundation | United Kingdom | PubMed | |
| AA/18/2/34218 | British Heart Foundation | United Kingdom | PubMed | |
| PG/20/22/35093 | British Heart Foundation | United Kingdom | PubMed | |
| PG/17/55/33087 | British Heart Foundation | United Kingdom | PubMed | |
| RG/17/15/33106 | British Heart Foundation | United Kingdom | PubMed | |
| FS/19/12/34204 | British Heart Foundation | United Kingdom | PubMed | |
| FS/19/16/34169 | British Heart Foundation | United Kingdom | PubMed | |
| PG/16/42/32142 | British Heart Foundation | United Kingdom | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 33785461 | Depolarization of the atrial resting membrane potential as an approach to enhance the anti-atrial fibrillation efficacy of sodium channel blockers. | https://conductscience.org/library/papers/33785461 |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24817686 | Small-conductance calcium-activated potassium (SK) channels contribute to action potential repolarization in human atria. | Cardiovasc Res | 2014 | https://conductscience.org/library/papers/24817686 | PubMed |
| 2 | 30718782 | ElectroMap: High-throughput open-source software for analysis and mapping of cardiac electrophysiology. | Sci Rep | 2019 | https://conductscience.org/library/papers/30718782 | PubMed |
| 3 | 20457925 | Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20457925 | PubMed |
| 4 | 32717172 | Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective. | Circ Res | 2020 | https://conductscience.org/library/papers/32717172 | PubMed |
| 5 | 11684070 | The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation. | Cardiovasc Res | 2001 | https://conductscience.org/library/papers/11684070 | PubMed |
| 6 | 30356673 | Profibrotic, Electrical, and Calcium-Handling Remodeling of the Atria in Heart Failure Patients With and Without Atrial Fibrillation. | Front Physiol | 2018 | https://conductscience.org/library/papers/30356673 | PubMed |
| 7 | 27567408 | 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. | Eur Heart J | 2016 | https://conductscience.org/library/papers/27567408 | PubMed |
| 8 | 32865375 | Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32865375 | PubMed |
| 9 | 29211857 | PulmOnary vein isolation With vs. without continued antiarrhythmic Drug trEatment in subjects with Recurrent Atrial Fibrillation (POWDER AF): results from a multicentre randomized trial. | Eur Heart J | 2018 | https://conductscience.org/library/papers/29211857 | PubMed |
| 10 | 22005044 | Atrial-selective sodium channel block strategy to suppress atrial fibrillation: ranolazine versus propafenone. | J Pharmacol Exp Ther | 2012 | https://conductscience.org/library/papers/22005044 | PubMed |
| 11 | 32814717 | Reduced left atrial cardiomyocyte PITX2 and elevated circulating BMP10 predict atrial fibrillation after ablation. | JCI Insight | 2020 | https://conductscience.org/library/papers/32814717 | PubMed |
| 12 | 32716721 | Genetics of Atrial Fibrillation in 2020: GWAS, Genome Sequencing, Polygenic Risk, and Beyond. | Circ Res | 2020 | https://conductscience.org/library/papers/32716721 | PubMed |
| 13 | 9657478 | Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: antiarrhythmic and proarrhythmic effects. | Circulation | 1998 | https://conductscience.org/library/papers/9657478 | PubMed |
| 14 | 27765191 | PITX2 Modulates Atrial Membrane Potential and the Antiarrhythmic Effects of Sodium-Channel Blockers. | J Am Coll Cardiol | 2016 | https://conductscience.org/library/papers/27765191 | PubMed |
| 15 | 27502479 | A Simplified, Langendorff-Free Method for Concomitant Isolation of Viable Cardiac Myocytes and Nonmyocytes From the Adult Mouse Heart. | Circ Res | 2016 | https://conductscience.org/library/papers/27502479 | PubMed |
| 16 | 21867730 | Novel pharmacological targets for the rhythm control management of atrial fibrillation. | Pharmacol Ther | 2011 | https://conductscience.org/library/papers/21867730 | PubMed |
| 17 | 29980180 | Reference effect measures for quantifying, comparing and visualizing variation from random and fixed effects in non-normal multilevel models, with applications to site variation in medical procedure use and outcomes. | BMC Med Res Methodol | 2018 | https://conductscience.org/library/papers/29980180 | PubMed |
| 18 | 21279331 | Effect of dronedarone on Na+, Ca2+ and HCN channels. | Naunyn Schmiedebergs Arch Pharmacol | 2011 | https://conductscience.org/library/papers/21279331 | PubMed |
| 19 | 27149380 | A Regional Reduction in Ito and IKACh in the Murine Posterior Left Atrial Myocardium Is Associated with Action Potential Prolongation and Increased Ectopic Activity. | PLoS One | 2016 | https://conductscience.org/library/papers/27149380 | PubMed |
| 20 | 27866707 | A Functional Variant Associated with Atrial Fibrillation Regulates PITX2c Expression through TFAP2a. | Am J Hum Genet | 2016 | https://conductscience.org/library/papers/27866707 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42198882 | A titin truncating variant linked to atrial fibrillation increases atrial profibrotic signalling and cholinergic sensitivity. | Cardiovasc Res | 2026 | https://conductscience.org/library/papers/42198882 | PubMed |
| 41392710 | Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the 10th AFNET/EHRA consensus conference. | Europace | 2025 | https://conductscience.org/library/papers/41392710 | PubMed |
| 41331342 | The effect of clinically relevant changes in extracellular electrolyte concentrations on human atrial arrhythmias. | Commun Med (Lond) | 2025 | https://conductscience.org/library/papers/41331342 | PubMed |
| 41097045 | Single-Nucleotide Polymorphisms, PITX2 and Abnormal Electrical Activity in Atrial Fibrillation. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41097045 | PubMed |
| 40557493 | Early Atrial Remodeling Drives Arrhythmia in Fabry Disease. | Circ Arrhythm Electrophysiol | 2025 | https://conductscience.org/library/papers/40557493 | PubMed |
| 38362554 | Atrial fibrillation: pathophysiology, genetic and epigenetic mechanisms. | Lancet Reg Health Eur | 2024 | https://conductscience.org/library/papers/38362554 | PubMed |
| 38136208 | Natural Substances vs. Approved Drugs in the Treatment of Main Cardiovascular Disorders-Is There a Breakthrough? | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/38136208 | PubMed |
| 37371131 | Mechanisms of Atrial Fibrillation in Obstructive Sleep Apnoea. | Cells | 2023 | https://conductscience.org/library/papers/37371131 | PubMed |
| 36331951 | Exploring the neurogenic differentiation of human dental pulp stem cells. | PLoS One | 2022 | https://conductscience.org/library/papers/36331951 | PubMed |
| 35928934 | Ablation and antiarrhythmic drug effects on PITX2 +/- deficient atrial fibrillation: A computational modeling study. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/35928934 | PubMed |
| 35197863 | Basic Research Approaches to Evaluate Cardiac Arrhythmia in Heart Failure and Beyond. | Front Physiol | 2022 | https://conductscience.org/library/papers/35197863 | PubMed |
| 35114252 | Increased atrial effectiveness of flecainide conferred by altered biophysical properties of sodium channels. | J Mol Cell Cardiol | 2022 | https://conductscience.org/library/papers/35114252 | PubMed |
| 34299303 | Understanding PITX2-Dependent Atrial Fibrillation Mechanisms through Computational Models. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34299303 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| INA | 9118 | PubTator's text mining | https://conductscience.org/library/genes/9118 | NCBI Gene |
| PITX2 | 5308 | PubTator's text mining | https://conductscience.org/library/genes/5308 | NCBI Gene |
| SCN1B | 6324 | PubTator's text mining | https://conductscience.org/library/genes/6324 | NCBI Gene |
| SCN5A | 6331 | PubTator's text mining | https://conductscience.org/library/genes/6331 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33737232
GET https://conductscience.org/api/papers/v1/33737232/references?page=2